Global Drug Eluting Balloons (DEB) Market Growth 2026-2032
The global Drug Eluting Balloons (DEB) market size is predicted to grow from US$ 1487 million in 2025 to US$ 3521 million in 2032; it is expected to grow at a CAGR of 13.0% from 2026 to 2032.
A drug-eluting balloon is a non-stent technology in which the effective homogenous delivery of anti-proliferative drugs is processed by the vessel wall through an inflated balloon. This is done to restore luminal vascularity in order to treat atherosclerosis, in-stent restenosis and reduce the risk of late thrombosis without implanting a permanent foreign object. The balloon technology relies on the concept of targeted drug delivery, which helps in the rapid healing of the vessel wall and prevents the proliferation of smooth muscle cells. Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure. In 2025, global drug-eluting balloon production reached approximately 1528 k units and price is 995 USD/Unit.The average gross profit margin of this product is 73%.
The Drug Eluting Balloons (DEB) market is being driven by the increasing global prevalence of cardiovascular diseases, particularly peripheral artery disease (PAD) and coronary artery disease (CAD). DEBs offer an effective alternative to traditional stents by delivering antiproliferative drugs directly to the vessel wall without leaving a permanent implant, reducing restenosis rates and improving long-term outcomes. Growing patient preference for minimally invasive procedures and shorter recovery times is also contributing to the adoption of DEBs. Furthermore, advancements in drug delivery technologies and increased clinical evidence supporting DEB efficacy are encouraging broader usage, especially among high-risk patients.
Despite their benefits, the DEB market faces several challenges. One key issue is the lack of uniform clinical guidelines and inconsistent results from clinical trials, which may hinder physician confidence and limit widespread adoption. Additionally, the high cost of DEBs compared to conventional balloons or bare-metal stents can be a barrier, particularly in emerging economies with limited healthcare budgets. Regulatory complexities and lengthy approval processes also pose significant hurdles for manufacturers. Furthermore, reimbursement policies vary across regions, creating market access disparities and limiting patient availability to these advanced therapies.
The DEB market is witnessing key trends such as the development of next-generation balloons with enhanced drug coatings and more efficient drug release profiles. There is growing interest in DEBs for treating new indications beyond peripheral and coronary artery disease, such as in-stent restenosis, small vessel disease, and arteriovenous fistula stenosis. Integration of imaging technologies, like intravascular ultrasound (IVUS) and optical coherence tomography (OCT), is also improving procedural outcomes. Additionally, strategic collaborations between medtech companies and research institutions are accelerating innovation, while increasing focus on personalized medicine is expected to drive customized DEB solutions in the near future.
LP Information, Inc. (LPI) ' newest research report, the ?Drug Eluting Balloons (DEB) Industry Forecast? looks at past sales and reviews total world Drug Eluting Balloons (DEB) sales in 2025, providing a comprehensive analysis by region and market sector of projected Drug Eluting Balloons (DEB) sales for 2026 through 2032. With Drug Eluting Balloons (DEB) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Eluting Balloons (DEB) industry.
This Insight Report provides a comprehensive analysis of the global Drug Eluting Balloons (DEB) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Eluting Balloons (DEB) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Drug Eluting Balloons (DEB) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Eluting Balloons (DEB) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Eluting Balloons (DEB).
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Eluting Balloons (DEB) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
A drug-eluting balloon is a non-stent technology in which the effective homogenous delivery of anti-proliferative drugs is processed by the vessel wall through an inflated balloon. This is done to restore luminal vascularity in order to treat atherosclerosis, in-stent restenosis and reduce the risk of late thrombosis without implanting a permanent foreign object. The balloon technology relies on the concept of targeted drug delivery, which helps in the rapid healing of the vessel wall and prevents the proliferation of smooth muscle cells. Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure. In 2025, global drug-eluting balloon production reached approximately 1528 k units and price is 995 USD/Unit.The average gross profit margin of this product is 73%.
The Drug Eluting Balloons (DEB) market is being driven by the increasing global prevalence of cardiovascular diseases, particularly peripheral artery disease (PAD) and coronary artery disease (CAD). DEBs offer an effective alternative to traditional stents by delivering antiproliferative drugs directly to the vessel wall without leaving a permanent implant, reducing restenosis rates and improving long-term outcomes. Growing patient preference for minimally invasive procedures and shorter recovery times is also contributing to the adoption of DEBs. Furthermore, advancements in drug delivery technologies and increased clinical evidence supporting DEB efficacy are encouraging broader usage, especially among high-risk patients.
Despite their benefits, the DEB market faces several challenges. One key issue is the lack of uniform clinical guidelines and inconsistent results from clinical trials, which may hinder physician confidence and limit widespread adoption. Additionally, the high cost of DEBs compared to conventional balloons or bare-metal stents can be a barrier, particularly in emerging economies with limited healthcare budgets. Regulatory complexities and lengthy approval processes also pose significant hurdles for manufacturers. Furthermore, reimbursement policies vary across regions, creating market access disparities and limiting patient availability to these advanced therapies.
The DEB market is witnessing key trends such as the development of next-generation balloons with enhanced drug coatings and more efficient drug release profiles. There is growing interest in DEBs for treating new indications beyond peripheral and coronary artery disease, such as in-stent restenosis, small vessel disease, and arteriovenous fistula stenosis. Integration of imaging technologies, like intravascular ultrasound (IVUS) and optical coherence tomography (OCT), is also improving procedural outcomes. Additionally, strategic collaborations between medtech companies and research institutions are accelerating innovation, while increasing focus on personalized medicine is expected to drive customized DEB solutions in the near future.
LP Information, Inc. (LPI) ' newest research report, the ?Drug Eluting Balloons (DEB) Industry Forecast? looks at past sales and reviews total world Drug Eluting Balloons (DEB) sales in 2025, providing a comprehensive analysis by region and market sector of projected Drug Eluting Balloons (DEB) sales for 2026 through 2032. With Drug Eluting Balloons (DEB) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Eluting Balloons (DEB) industry.
This Insight Report provides a comprehensive analysis of the global Drug Eluting Balloons (DEB) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Eluting Balloons (DEB) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Drug Eluting Balloons (DEB) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Eluting Balloons (DEB) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Eluting Balloons (DEB).
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Eluting Balloons (DEB) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Peripheral DEBs
- Coronary DEBs
- In-Stent Restenosi
- De Novo
- Small Vessel
- Semi-/Compliant
- Non-compliant
- Other
- Catheterization Laboratory
- Hospital
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- B. Braun
- Medtronic
- Boston Scientific
- BD
- Yinyi Biotechnology
- Acotec
- Philips
- Lepu Medical
- Eurocor
- MicroPort Medical
- Teleflex
- What is the 10-year outlook for the global Drug Eluting Balloons (DEB) market?
- What factors are driving Drug Eluting Balloons (DEB) market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How doDrug Eluting Balloons (DEB) market opportunities vary by end market size?
- How does Drug Eluting Balloons (DEB) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Eluting Balloons (DEB) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Drug Eluting Balloons (DEB) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Drug Eluting Balloons (DEB) by Country/Region, 2021, 2025 & 2032
2.2 Drug Eluting Balloons (DEB) Segment by Type
2.2.1 Peripheral DEBs
2.2.2 Coronary DEBs
2.2.3 Drug Eluting Balloons (DEB) Sales by Type
2.2.3.1 Global Drug Eluting Balloons (DEB) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Drug Eluting Balloons (DEB) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Drug Eluting Balloons (DEB) Sale Price by Type (2021-2026)
2.3 Drug Eluting Balloons (DEB) Segment by Use Scenario
2.3.1 In-Stent Restenosi
2.3.2 De Novo
2.3.3 Small Vessel
2.3.4 Drug Eluting Balloons (DEB) Sales by Use Scenario
2.3.4.1 Global Drug Eluting Balloons (DEB) Sales Market Share by Use Scenario (2021-2026)
2.3.4.2 Global Drug Eluting Balloons (DEB) Revenue and Market Share by Use Scenario (2021-2026)
2.3.4.3 Global Drug Eluting Balloons (DEB) Sale Price by Use Scenario (2021-2026)
2.4 Drug Eluting Balloons (DEB) Segment by Balloon Platform Mechanics
2.4.1 Semi-/Compliant
2.4.2 Non-compliant
2.4.3 Other
2.4.4 Drug Eluting Balloons (DEB) Sales by Balloon Platform Mechanics
2.4.4.1 Global Drug Eluting Balloons (DEB) Sales Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.2 Global Drug Eluting Balloons (DEB) Revenue and Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.3 Global Drug Eluting Balloons (DEB) Sale Price by Balloon Platform Mechanics (2021-2026)
2.5 Drug Eluting Balloons (DEB) Segment by Application
2.5.1 Catheterization Laboratory
2.5.2 Hospital
2.5.3 Others
2.5.4 Drug Eluting Balloons (DEB) Sales by Application
2.5.4.1 Global Drug Eluting Balloons (DEB) Sale Market Share by Application (2021-2026)
2.5.4.2 Global Drug Eluting Balloons (DEB) Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Drug Eluting Balloons (DEB) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Drug Eluting Balloons (DEB) Breakdown Data by Company
3.1.1 Global Drug Eluting Balloons (DEB) Annual Sales by Company (2021-2026)
3.1.2 Global Drug Eluting Balloons (DEB) Sales Market Share by Company (2021-2026)
3.2 Global Drug Eluting Balloons (DEB) Annual Revenue by Company (2021-2026)
3.2.1 Global Drug Eluting Balloons (DEB) Revenue by Company (2021-2026)
3.2.2 Global Drug Eluting Balloons (DEB) Revenue Market Share by Company (2021-2026)
3.3 Global Drug Eluting Balloons (DEB) Sale Price by Company
3.4 Key Manufacturers Drug Eluting Balloons (DEB) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug Eluting Balloons (DEB) Product Location Distribution
3.4.2 Players Drug Eluting Balloons (DEB) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DRUG ELUTING BALLOONS (DEB) BY GEOGRAPHIC REGION
4.1 World Historic Drug Eluting Balloons (DEB) Market Size by Geographic Region (2021-2026)
4.1.1 Global Drug Eluting Balloons (DEB) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Drug Eluting Balloons (DEB) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Drug Eluting Balloons (DEB) Market Size by Country/Region (2021-2026)
4.2.1 Global Drug Eluting Balloons (DEB) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Drug Eluting Balloons (DEB) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Drug Eluting Balloons (DEB) Sales Growth
4.4 APAC Drug Eluting Balloons (DEB) Sales Growth
4.5 Europe Drug Eluting Balloons (DEB) Sales Growth
4.6 Middle East & Africa Drug Eluting Balloons (DEB) Sales Growth
5 AMERICAS
5.1 Americas Drug Eluting Balloons (DEB) Sales by Country
5.1.1 Americas Drug Eluting Balloons (DEB) Sales by Country (2021-2026)
5.1.2 Americas Drug Eluting Balloons (DEB) Revenue by Country (2021-2026)
5.2 Americas Drug Eluting Balloons (DEB) Sales by Type (2021-2026)
5.3 Americas Drug Eluting Balloons (DEB) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Eluting Balloons (DEB) Sales by Region
6.1.1 APAC Drug Eluting Balloons (DEB) Sales by Region (2021-2026)
6.1.2 APAC Drug Eluting Balloons (DEB) Revenue by Region (2021-2026)
6.2 APAC Drug Eluting Balloons (DEB) Sales by Type (2021-2026)
6.3 APAC Drug Eluting Balloons (DEB) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug Eluting Balloons (DEB) by Country
7.1.1 Europe Drug Eluting Balloons (DEB) Sales by Country (2021-2026)
7.1.2 Europe Drug Eluting Balloons (DEB) Revenue by Country (2021-2026)
7.2 Europe Drug Eluting Balloons (DEB) Sales by Type (2021-2026)
7.3 Europe Drug Eluting Balloons (DEB) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Eluting Balloons (DEB) by Country
8.1.1 Middle East & Africa Drug Eluting Balloons (DEB) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Drug Eluting Balloons (DEB) Revenue by Country (2021-2026)
8.2 Middle East & Africa Drug Eluting Balloons (DEB) Sales by Type (2021-2026)
8.3 Middle East & Africa Drug Eluting Balloons (DEB) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug Eluting Balloons (DEB)
10.3 Manufacturing Process Analysis of Drug Eluting Balloons (DEB)
10.4 Industry Chain Structure of Drug Eluting Balloons (DEB)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug Eluting Balloons (DEB) Distributors
11.3 Drug Eluting Balloons (DEB) Customer
12 WORLD FORECAST REVIEW FOR DRUG ELUTING BALLOONS (DEB) BY GEOGRAPHIC REGION
12.1 Global Drug Eluting Balloons (DEB) Market Size Forecast by Region
12.1.1 Global Drug Eluting Balloons (DEB) Forecast by Region (2027-2032)
12.1.2 Global Drug Eluting Balloons (DEB) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Drug Eluting Balloons (DEB) Forecast by Type (2027-2032)
12.7 Global Drug Eluting Balloons (DEB) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 B. Braun
13.1.1 B. Braun Company Information
13.1.2 B. Braun Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.1.3 B. Braun Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 B. Braun Main Business Overview
13.1.5 B. Braun Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.2.3 Medtronic Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Boston Scientific
13.3.1 Boston Scientific Company Information
13.3.2 Boston Scientific Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.3.3 Boston Scientific Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boston Scientific Main Business Overview
13.3.5 Boston Scientific Latest Developments
13.4 BD
13.4.1 BD Company Information
13.4.2 BD Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.4.3 BD Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BD Main Business Overview
13.4.5 BD Latest Developments
13.5 Yinyi Biotechnology
13.5.1 Yinyi Biotechnology Company Information
13.5.2 Yinyi Biotechnology Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.5.3 Yinyi Biotechnology Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yinyi Biotechnology Main Business Overview
13.5.5 Yinyi Biotechnology Latest Developments
13.6 Acotec
13.6.1 Acotec Company Information
13.6.2 Acotec Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.6.3 Acotec Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Acotec Main Business Overview
13.6.5 Acotec Latest Developments
13.7 Philips
13.7.1 Philips Company Information
13.7.2 Philips Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.7.3 Philips Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Philips Main Business Overview
13.7.5 Philips Latest Developments
13.8 Lepu Medical
13.8.1 Lepu Medical Company Information
13.8.2 Lepu Medical Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.8.3 Lepu Medical Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Lepu Medical Main Business Overview
13.8.5 Lepu Medical Latest Developments
13.9 Eurocor
13.9.1 Eurocor Company Information
13.9.2 Eurocor Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.9.3 Eurocor Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Eurocor Main Business Overview
13.9.5 Eurocor Latest Developments
13.10 MicroPort Medical
13.10.1 MicroPort Medical Company Information
13.10.2 MicroPort Medical Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.10.3 MicroPort Medical Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 MicroPort Medical Main Business Overview
13.10.5 MicroPort Medical Latest Developments
13.11 Teleflex
13.11.1 Teleflex Company Information
13.11.2 Teleflex Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.11.3 Teleflex Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Teleflex Main Business Overview
13.11.5 Teleflex Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Eluting Balloons (DEB) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Drug Eluting Balloons (DEB) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Drug Eluting Balloons (DEB) by Country/Region, 2021, 2025 & 2032
2.2 Drug Eluting Balloons (DEB) Segment by Type
2.2.1 Peripheral DEBs
2.2.2 Coronary DEBs
2.2.3 Drug Eluting Balloons (DEB) Sales by Type
2.2.3.1 Global Drug Eluting Balloons (DEB) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Drug Eluting Balloons (DEB) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Drug Eluting Balloons (DEB) Sale Price by Type (2021-2026)
2.3 Drug Eluting Balloons (DEB) Segment by Use Scenario
2.3.1 In-Stent Restenosi
2.3.2 De Novo
2.3.3 Small Vessel
2.3.4 Drug Eluting Balloons (DEB) Sales by Use Scenario
2.3.4.1 Global Drug Eluting Balloons (DEB) Sales Market Share by Use Scenario (2021-2026)
2.3.4.2 Global Drug Eluting Balloons (DEB) Revenue and Market Share by Use Scenario (2021-2026)
2.3.4.3 Global Drug Eluting Balloons (DEB) Sale Price by Use Scenario (2021-2026)
2.4 Drug Eluting Balloons (DEB) Segment by Balloon Platform Mechanics
2.4.1 Semi-/Compliant
2.4.2 Non-compliant
2.4.3 Other
2.4.4 Drug Eluting Balloons (DEB) Sales by Balloon Platform Mechanics
2.4.4.1 Global Drug Eluting Balloons (DEB) Sales Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.2 Global Drug Eluting Balloons (DEB) Revenue and Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.3 Global Drug Eluting Balloons (DEB) Sale Price by Balloon Platform Mechanics (2021-2026)
2.5 Drug Eluting Balloons (DEB) Segment by Application
2.5.1 Catheterization Laboratory
2.5.2 Hospital
2.5.3 Others
2.5.4 Drug Eluting Balloons (DEB) Sales by Application
2.5.4.1 Global Drug Eluting Balloons (DEB) Sale Market Share by Application (2021-2026)
2.5.4.2 Global Drug Eluting Balloons (DEB) Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Drug Eluting Balloons (DEB) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Drug Eluting Balloons (DEB) Breakdown Data by Company
3.1.1 Global Drug Eluting Balloons (DEB) Annual Sales by Company (2021-2026)
3.1.2 Global Drug Eluting Balloons (DEB) Sales Market Share by Company (2021-2026)
3.2 Global Drug Eluting Balloons (DEB) Annual Revenue by Company (2021-2026)
3.2.1 Global Drug Eluting Balloons (DEB) Revenue by Company (2021-2026)
3.2.2 Global Drug Eluting Balloons (DEB) Revenue Market Share by Company (2021-2026)
3.3 Global Drug Eluting Balloons (DEB) Sale Price by Company
3.4 Key Manufacturers Drug Eluting Balloons (DEB) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug Eluting Balloons (DEB) Product Location Distribution
3.4.2 Players Drug Eluting Balloons (DEB) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DRUG ELUTING BALLOONS (DEB) BY GEOGRAPHIC REGION
4.1 World Historic Drug Eluting Balloons (DEB) Market Size by Geographic Region (2021-2026)
4.1.1 Global Drug Eluting Balloons (DEB) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Drug Eluting Balloons (DEB) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Drug Eluting Balloons (DEB) Market Size by Country/Region (2021-2026)
4.2.1 Global Drug Eluting Balloons (DEB) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Drug Eluting Balloons (DEB) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Drug Eluting Balloons (DEB) Sales Growth
4.4 APAC Drug Eluting Balloons (DEB) Sales Growth
4.5 Europe Drug Eluting Balloons (DEB) Sales Growth
4.6 Middle East & Africa Drug Eluting Balloons (DEB) Sales Growth
5 AMERICAS
5.1 Americas Drug Eluting Balloons (DEB) Sales by Country
5.1.1 Americas Drug Eluting Balloons (DEB) Sales by Country (2021-2026)
5.1.2 Americas Drug Eluting Balloons (DEB) Revenue by Country (2021-2026)
5.2 Americas Drug Eluting Balloons (DEB) Sales by Type (2021-2026)
5.3 Americas Drug Eluting Balloons (DEB) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Eluting Balloons (DEB) Sales by Region
6.1.1 APAC Drug Eluting Balloons (DEB) Sales by Region (2021-2026)
6.1.2 APAC Drug Eluting Balloons (DEB) Revenue by Region (2021-2026)
6.2 APAC Drug Eluting Balloons (DEB) Sales by Type (2021-2026)
6.3 APAC Drug Eluting Balloons (DEB) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug Eluting Balloons (DEB) by Country
7.1.1 Europe Drug Eluting Balloons (DEB) Sales by Country (2021-2026)
7.1.2 Europe Drug Eluting Balloons (DEB) Revenue by Country (2021-2026)
7.2 Europe Drug Eluting Balloons (DEB) Sales by Type (2021-2026)
7.3 Europe Drug Eluting Balloons (DEB) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Eluting Balloons (DEB) by Country
8.1.1 Middle East & Africa Drug Eluting Balloons (DEB) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Drug Eluting Balloons (DEB) Revenue by Country (2021-2026)
8.2 Middle East & Africa Drug Eluting Balloons (DEB) Sales by Type (2021-2026)
8.3 Middle East & Africa Drug Eluting Balloons (DEB) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug Eluting Balloons (DEB)
10.3 Manufacturing Process Analysis of Drug Eluting Balloons (DEB)
10.4 Industry Chain Structure of Drug Eluting Balloons (DEB)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug Eluting Balloons (DEB) Distributors
11.3 Drug Eluting Balloons (DEB) Customer
12 WORLD FORECAST REVIEW FOR DRUG ELUTING BALLOONS (DEB) BY GEOGRAPHIC REGION
12.1 Global Drug Eluting Balloons (DEB) Market Size Forecast by Region
12.1.1 Global Drug Eluting Balloons (DEB) Forecast by Region (2027-2032)
12.1.2 Global Drug Eluting Balloons (DEB) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Drug Eluting Balloons (DEB) Forecast by Type (2027-2032)
12.7 Global Drug Eluting Balloons (DEB) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 B. Braun
13.1.1 B. Braun Company Information
13.1.2 B. Braun Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.1.3 B. Braun Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 B. Braun Main Business Overview
13.1.5 B. Braun Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.2.3 Medtronic Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Boston Scientific
13.3.1 Boston Scientific Company Information
13.3.2 Boston Scientific Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.3.3 Boston Scientific Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boston Scientific Main Business Overview
13.3.5 Boston Scientific Latest Developments
13.4 BD
13.4.1 BD Company Information
13.4.2 BD Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.4.3 BD Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BD Main Business Overview
13.4.5 BD Latest Developments
13.5 Yinyi Biotechnology
13.5.1 Yinyi Biotechnology Company Information
13.5.2 Yinyi Biotechnology Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.5.3 Yinyi Biotechnology Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yinyi Biotechnology Main Business Overview
13.5.5 Yinyi Biotechnology Latest Developments
13.6 Acotec
13.6.1 Acotec Company Information
13.6.2 Acotec Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.6.3 Acotec Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Acotec Main Business Overview
13.6.5 Acotec Latest Developments
13.7 Philips
13.7.1 Philips Company Information
13.7.2 Philips Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.7.3 Philips Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Philips Main Business Overview
13.7.5 Philips Latest Developments
13.8 Lepu Medical
13.8.1 Lepu Medical Company Information
13.8.2 Lepu Medical Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.8.3 Lepu Medical Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Lepu Medical Main Business Overview
13.8.5 Lepu Medical Latest Developments
13.9 Eurocor
13.9.1 Eurocor Company Information
13.9.2 Eurocor Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.9.3 Eurocor Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Eurocor Main Business Overview
13.9.5 Eurocor Latest Developments
13.10 MicroPort Medical
13.10.1 MicroPort Medical Company Information
13.10.2 MicroPort Medical Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.10.3 MicroPort Medical Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 MicroPort Medical Main Business Overview
13.10.5 MicroPort Medical Latest Developments
13.11 Teleflex
13.11.1 Teleflex Company Information
13.11.2 Teleflex Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.11.3 Teleflex Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Teleflex Main Business Overview
13.11.5 Teleflex Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug Eluting Balloons (DEB) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Drug Eluting Balloons (DEB) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Peripheral DEBs
Table 4. Major Players of Coronary DEBs
Table 5. Global Drug Eluting Balloons (DEB) Sales by Type (2021-2026) & (K Units)
Table 6. Global Drug Eluting Balloons (DEB) Sales Market Share by Type (2021-2026)
Table 7. Global Drug Eluting Balloons (DEB) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Drug Eluting Balloons (DEB) Revenue Market Share by Type (2021-2026)
Table 9. Global Drug Eluting Balloons (DEB) Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of In-Stent Restenosi
Table 11. Major Players of De Novo
Table 12. Major Players of Small Vessel
Table 13. Global Drug Eluting Balloons (DEB) Sales by Use Scenario (2021-2026) & (K Units)
Table 14. Global Drug Eluting Balloons (DEB) Sales Market Share by Use Scenario (2021-2026)
Table 15. Global Drug Eluting Balloons (DEB) Revenue by Use Scenario (2021-2026) & ($ million)
Table 16. Global Drug Eluting Balloons (DEB) Revenue Market Share by Use Scenario (2021-2026)
Table 17. Global Drug Eluting Balloons (DEB) Sale Price by Use Scenario (2021-2026) & (US$/Unit)
Table 18. Major Players of Semi-/Compliant
Table 19. Major Players of Non-compliant
Table 20. Major Players of Other
Table 21. Global Drug Eluting Balloons (DEB) Sales by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 22. Global Drug Eluting Balloons (DEB) Sales Market Share by Balloon Platform Mechanics (2021-2026)
Table 23. Global Drug Eluting Balloons (DEB) Revenue by Balloon Platform Mechanics (2021-2026) & ($ million)
Table 24. Global Drug Eluting Balloons (DEB) Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Table 25. Global Drug Eluting Balloons (DEB) Sale Price by Balloon Platform Mechanics (2021-2026) & (US$/Unit)
Table 26. Global Drug Eluting Balloons (DEB) Sale by Application (2021-2026) & (K Units)
Table 27. Global Drug Eluting Balloons (DEB) Sale Market Share by Application (2021-2026)
Table 28. Global Drug Eluting Balloons (DEB) Revenue by Application (2021-2026) & ($ million)
Table 29. Global Drug Eluting Balloons (DEB) Revenue Market Share by Application (2021-2026)
Table 30. Global Drug Eluting Balloons (DEB) Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Drug Eluting Balloons (DEB) Sales by Company (2021-2026) & (K Units)
Table 32. Global Drug Eluting Balloons (DEB) Sales Market Share by Company (2021-2026)
Table 33. Global Drug Eluting Balloons (DEB) Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Drug Eluting Balloons (DEB) Revenue Market Share by Company (2021-2026)
Table 35. Global Drug Eluting Balloons (DEB) Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Drug Eluting Balloons (DEB) Producing Area Distribution and Sales Area
Table 37. Players Drug Eluting Balloons (DEB) Products Offered
Table 38. Drug Eluting Balloons (DEB) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Drug Eluting Balloons (DEB) Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Drug Eluting Balloons (DEB) Sales Market Share Geographic Region (2021-2026)
Table 43. Global Drug Eluting Balloons (DEB) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Drug Eluting Balloons (DEB) Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Drug Eluting Balloons (DEB) Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Drug Eluting Balloons (DEB) Sales Market Share by Country/Region (2021-2026)
Table 47. Global Drug Eluting Balloons (DEB) Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Drug Eluting Balloons (DEB) Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Drug Eluting Balloons (DEB) Sales by Country (2021-2026) & (K Units)
Table 50. Americas Drug Eluting Balloons (DEB) Sales Market Share by Country (2021-2026)
Table 51. Americas Drug Eluting Balloons (DEB) Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Drug Eluting Balloons (DEB) Sales by Type (2021-2026) & (K Units)
Table 53. Americas Drug Eluting Balloons (DEB) Sales by Application (2021-2026) & (K Units)
Table 54. APAC Drug Eluting Balloons (DEB) Sales by Region (2021-2026) & (K Units)
Table 55. APAC Drug Eluting Balloons (DEB) Sales Market Share by Region (2021-2026)
Table 56. APAC Drug Eluting Balloons (DEB) Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Drug Eluting Balloons (DEB) Sales by Type (2021-2026) & (K Units)
Table 58. APAC Drug Eluting Balloons (DEB) Sales by Application (2021-2026) & (K Units)
Table 59. Europe Drug Eluting Balloons (DEB) Sales by Country (2021-2026) & (K Units)
Table 60. Europe Drug Eluting Balloons (DEB) Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Drug Eluting Balloons (DEB) Sales by Type (2021-2026) & (K Units)
Table 62. Europe Drug Eluting Balloons (DEB) Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Drug Eluting Balloons (DEB) Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Drug Eluting Balloons (DEB) Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Drug Eluting Balloons (DEB) Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Drug Eluting Balloons (DEB) Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Drug Eluting Balloons (DEB)
Table 68. Key Market Challenges & Risks of Drug Eluting Balloons (DEB)
Table 69. Key Industry Trends of Drug Eluting Balloons (DEB)
Table 70. Drug Eluting Balloons (DEB) Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Drug Eluting Balloons (DEB) Distributors List
Table 73. Drug Eluting Balloons (DEB) Customer List
Table 74. Global Drug Eluting Balloons (DEB) Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Drug Eluting Balloons (DEB) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Drug Eluting Balloons (DEB) Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Drug Eluting Balloons (DEB) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Drug Eluting Balloons (DEB) Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Drug Eluting Balloons (DEB) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Drug Eluting Balloons (DEB) Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Drug Eluting Balloons (DEB) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Drug Eluting Balloons (DEB) Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Drug Eluting Balloons (DEB) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Drug Eluting Balloons (DEB) Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Drug Eluting Balloons (DEB) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Drug Eluting Balloons (DEB) Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Drug Eluting Balloons (DEB) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. B. Braun Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 89. B. Braun Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 90. B. Braun Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. B. Braun Main Business
Table 92. B. Braun Latest Developments
Table 93. Medtronic Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 94. Medtronic Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 95. Medtronic Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Medtronic Main Business
Table 97. Medtronic Latest Developments
Table 98. Boston Scientific Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 99. Boston Scientific Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 100. Boston Scientific Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Boston Scientific Main Business
Table 102. Boston Scientific Latest Developments
Table 103. BD Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 104. BD Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 105. BD Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. BD Main Business
Table 107. BD Latest Developments
Table 108. Yinyi Biotechnology Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 109. Yinyi Biotechnology Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 110. Yinyi Biotechnology Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Yinyi Biotechnology Main Business
Table 112. Yinyi Biotechnology Latest Developments
Table 113. Acotec Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 114. Acotec Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 115. Acotec Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Acotec Main Business
Table 117. Acotec Latest Developments
Table 118. Philips Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 119. Philips Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 120. Philips Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Philips Main Business
Table 122. Philips Latest Developments
Table 123. Lepu Medical Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 124. Lepu Medical Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 125. Lepu Medical Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Lepu Medical Main Business
Table 127. Lepu Medical Latest Developments
Table 128. Eurocor Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 129. Eurocor Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 130. Eurocor Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Eurocor Main Business
Table 132. Eurocor Latest Developments
Table 133. MicroPort Medical Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 134. MicroPort Medical Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 135. MicroPort Medical Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. MicroPort Medical Main Business
Table 137. MicroPort Medical Latest Developments
Table 138. Teleflex Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 139. Teleflex Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 140. Teleflex Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Teleflex Main Business
Table 142. Teleflex Latest Developments
Table 1. Drug Eluting Balloons (DEB) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Drug Eluting Balloons (DEB) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Peripheral DEBs
Table 4. Major Players of Coronary DEBs
Table 5. Global Drug Eluting Balloons (DEB) Sales by Type (2021-2026) & (K Units)
Table 6. Global Drug Eluting Balloons (DEB) Sales Market Share by Type (2021-2026)
Table 7. Global Drug Eluting Balloons (DEB) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Drug Eluting Balloons (DEB) Revenue Market Share by Type (2021-2026)
Table 9. Global Drug Eluting Balloons (DEB) Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of In-Stent Restenosi
Table 11. Major Players of De Novo
Table 12. Major Players of Small Vessel
Table 13. Global Drug Eluting Balloons (DEB) Sales by Use Scenario (2021-2026) & (K Units)
Table 14. Global Drug Eluting Balloons (DEB) Sales Market Share by Use Scenario (2021-2026)
Table 15. Global Drug Eluting Balloons (DEB) Revenue by Use Scenario (2021-2026) & ($ million)
Table 16. Global Drug Eluting Balloons (DEB) Revenue Market Share by Use Scenario (2021-2026)
Table 17. Global Drug Eluting Balloons (DEB) Sale Price by Use Scenario (2021-2026) & (US$/Unit)
Table 18. Major Players of Semi-/Compliant
Table 19. Major Players of Non-compliant
Table 20. Major Players of Other
Table 21. Global Drug Eluting Balloons (DEB) Sales by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 22. Global Drug Eluting Balloons (DEB) Sales Market Share by Balloon Platform Mechanics (2021-2026)
Table 23. Global Drug Eluting Balloons (DEB) Revenue by Balloon Platform Mechanics (2021-2026) & ($ million)
Table 24. Global Drug Eluting Balloons (DEB) Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Table 25. Global Drug Eluting Balloons (DEB) Sale Price by Balloon Platform Mechanics (2021-2026) & (US$/Unit)
Table 26. Global Drug Eluting Balloons (DEB) Sale by Application (2021-2026) & (K Units)
Table 27. Global Drug Eluting Balloons (DEB) Sale Market Share by Application (2021-2026)
Table 28. Global Drug Eluting Balloons (DEB) Revenue by Application (2021-2026) & ($ million)
Table 29. Global Drug Eluting Balloons (DEB) Revenue Market Share by Application (2021-2026)
Table 30. Global Drug Eluting Balloons (DEB) Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Drug Eluting Balloons (DEB) Sales by Company (2021-2026) & (K Units)
Table 32. Global Drug Eluting Balloons (DEB) Sales Market Share by Company (2021-2026)
Table 33. Global Drug Eluting Balloons (DEB) Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Drug Eluting Balloons (DEB) Revenue Market Share by Company (2021-2026)
Table 35. Global Drug Eluting Balloons (DEB) Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Drug Eluting Balloons (DEB) Producing Area Distribution and Sales Area
Table 37. Players Drug Eluting Balloons (DEB) Products Offered
Table 38. Drug Eluting Balloons (DEB) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Drug Eluting Balloons (DEB) Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Drug Eluting Balloons (DEB) Sales Market Share Geographic Region (2021-2026)
Table 43. Global Drug Eluting Balloons (DEB) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Drug Eluting Balloons (DEB) Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Drug Eluting Balloons (DEB) Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Drug Eluting Balloons (DEB) Sales Market Share by Country/Region (2021-2026)
Table 47. Global Drug Eluting Balloons (DEB) Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Drug Eluting Balloons (DEB) Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Drug Eluting Balloons (DEB) Sales by Country (2021-2026) & (K Units)
Table 50. Americas Drug Eluting Balloons (DEB) Sales Market Share by Country (2021-2026)
Table 51. Americas Drug Eluting Balloons (DEB) Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Drug Eluting Balloons (DEB) Sales by Type (2021-2026) & (K Units)
Table 53. Americas Drug Eluting Balloons (DEB) Sales by Application (2021-2026) & (K Units)
Table 54. APAC Drug Eluting Balloons (DEB) Sales by Region (2021-2026) & (K Units)
Table 55. APAC Drug Eluting Balloons (DEB) Sales Market Share by Region (2021-2026)
Table 56. APAC Drug Eluting Balloons (DEB) Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Drug Eluting Balloons (DEB) Sales by Type (2021-2026) & (K Units)
Table 58. APAC Drug Eluting Balloons (DEB) Sales by Application (2021-2026) & (K Units)
Table 59. Europe Drug Eluting Balloons (DEB) Sales by Country (2021-2026) & (K Units)
Table 60. Europe Drug Eluting Balloons (DEB) Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Drug Eluting Balloons (DEB) Sales by Type (2021-2026) & (K Units)
Table 62. Europe Drug Eluting Balloons (DEB) Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Drug Eluting Balloons (DEB) Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Drug Eluting Balloons (DEB) Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Drug Eluting Balloons (DEB) Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Drug Eluting Balloons (DEB) Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Drug Eluting Balloons (DEB)
Table 68. Key Market Challenges & Risks of Drug Eluting Balloons (DEB)
Table 69. Key Industry Trends of Drug Eluting Balloons (DEB)
Table 70. Drug Eluting Balloons (DEB) Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Drug Eluting Balloons (DEB) Distributors List
Table 73. Drug Eluting Balloons (DEB) Customer List
Table 74. Global Drug Eluting Balloons (DEB) Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Drug Eluting Balloons (DEB) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Drug Eluting Balloons (DEB) Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Drug Eluting Balloons (DEB) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Drug Eluting Balloons (DEB) Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Drug Eluting Balloons (DEB) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Drug Eluting Balloons (DEB) Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Drug Eluting Balloons (DEB) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Drug Eluting Balloons (DEB) Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Drug Eluting Balloons (DEB) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Drug Eluting Balloons (DEB) Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Drug Eluting Balloons (DEB) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Drug Eluting Balloons (DEB) Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Drug Eluting Balloons (DEB) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. B. Braun Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 89. B. Braun Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 90. B. Braun Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. B. Braun Main Business
Table 92. B. Braun Latest Developments
Table 93. Medtronic Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 94. Medtronic Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 95. Medtronic Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Medtronic Main Business
Table 97. Medtronic Latest Developments
Table 98. Boston Scientific Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 99. Boston Scientific Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 100. Boston Scientific Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Boston Scientific Main Business
Table 102. Boston Scientific Latest Developments
Table 103. BD Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 104. BD Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 105. BD Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. BD Main Business
Table 107. BD Latest Developments
Table 108. Yinyi Biotechnology Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 109. Yinyi Biotechnology Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 110. Yinyi Biotechnology Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Yinyi Biotechnology Main Business
Table 112. Yinyi Biotechnology Latest Developments
Table 113. Acotec Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 114. Acotec Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 115. Acotec Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Acotec Main Business
Table 117. Acotec Latest Developments
Table 118. Philips Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 119. Philips Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 120. Philips Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Philips Main Business
Table 122. Philips Latest Developments
Table 123. Lepu Medical Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 124. Lepu Medical Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 125. Lepu Medical Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Lepu Medical Main Business
Table 127. Lepu Medical Latest Developments
Table 128. Eurocor Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 129. Eurocor Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 130. Eurocor Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Eurocor Main Business
Table 132. Eurocor Latest Developments
Table 133. MicroPort Medical Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 134. MicroPort Medical Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 135. MicroPort Medical Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. MicroPort Medical Main Business
Table 137. MicroPort Medical Latest Developments
Table 138. Teleflex Basic Information, Drug Eluting Balloons (DEB) Manufacturing Base, Sales Area and Its Competitors
Table 139. Teleflex Drug Eluting Balloons (DEB) Product Portfolios and Specifications
Table 140. Teleflex Drug Eluting Balloons (DEB) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Teleflex Main Business
Table 142. Teleflex Latest Developments
LIST OF FIGURES
Figure 1. Picture of Drug Eluting Balloons (DEB)
Figure 2. Drug Eluting Balloons (DEB) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug Eluting Balloons (DEB) Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Drug Eluting Balloons (DEB) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Drug Eluting Balloons (DEB) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Drug Eluting Balloons (DEB) Sales Market Share by Country/Region (2025)
Figure 10. Drug Eluting Balloons (DEB) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Peripheral DEBs
Figure 12. Product Picture of Coronary DEBs
Figure 13. Global Drug Eluting Balloons (DEB) Sales Market Share by Type in 2026
Figure 14. Global Drug Eluting Balloons (DEB) Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of In-Stent Restenosi
Figure 16. Product Picture of De Novo
Figure 17. Product Picture of Small Vessel
Figure 18. Global Drug Eluting Balloons (DEB) Sales Market Share by Use Scenario in 2026
Figure 19. Global Drug Eluting Balloons (DEB) Revenue Market Share by Use Scenario (2021-2026)
Figure 20. Product Picture of Semi-/Compliant
Figure 21. Product Picture of Non-compliant
Figure 22. Product Picture of Other
Figure 23. Global Drug Eluting Balloons (DEB) Sales Market Share by Balloon Platform Mechanics in 2026
Figure 24. Global Drug Eluting Balloons (DEB) Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Figure 25. Drug Eluting Balloons (DEB) Consumed in Catheterization Laboratory
Figure 26. Global Drug Eluting Balloons (DEB) Market: Catheterization Laboratory (2021-2026) & (K Units)
Figure 27. Drug Eluting Balloons (DEB) Consumed in Hospital
Figure 28. Global Drug Eluting Balloons (DEB) Market: Hospital (2021-2026) & (K Units)
Figure 29. Drug Eluting Balloons (DEB) Consumed in Others
Figure 30. Global Drug Eluting Balloons (DEB) Market: Others (2021-2026) & (K Units)
Figure 31. Global Drug Eluting Balloons (DEB) Sale Market Share by Application (2025)
Figure 32. Global Drug Eluting Balloons (DEB) Revenue Market Share by Application in 2026
Figure 33. Drug Eluting Balloons (DEB) Sales by Company in 2026 (K Units)
Figure 34. Global Drug Eluting Balloons (DEB) Sales Market Share by Company in 2026
Figure 35. Drug Eluting Balloons (DEB) Revenue by Company in 2026 ($ millions)
Figure 36. Global Drug Eluting Balloons (DEB) Revenue Market Share by Company in 2026
Figure 37. Global Drug Eluting Balloons (DEB) Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Drug Eluting Balloons (DEB) Revenue Market Share by Geographic Region in 2026
Figure 39. Americas Drug Eluting Balloons (DEB) Sales 2021-2026 (K Units)
Figure 40. Americas Drug Eluting Balloons (DEB) Revenue 2021-2026 ($ millions)
Figure 41. APAC Drug Eluting Balloons (DEB) Sales 2021-2026 (K Units)
Figure 42. APAC Drug Eluting Balloons (DEB) Revenue 2021-2026 ($ millions)
Figure 43. Europe Drug Eluting Balloons (DEB) Sales 2021-2026 (K Units)
Figure 44. Europe Drug Eluting Balloons (DEB) Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Drug Eluting Balloons (DEB) Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Drug Eluting Balloons (DEB) Revenue 2021-2026 ($ millions)
Figure 47. Americas Drug Eluting Balloons (DEB) Sales Market Share by Country in 2026
Figure 48. Americas Drug Eluting Balloons (DEB) Revenue Market Share by Country (2021-2026)
Figure 49. Americas Drug Eluting Balloons (DEB) Sales Market Share by Type (2021-2026)
Figure 50. Americas Drug Eluting Balloons (DEB) Sales Market Share by Application (2021-2026)
Figure 51. United States Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Drug Eluting Balloons (DEB) Sales Market Share by Region in 2026
Figure 56. APAC Drug Eluting Balloons (DEB) Revenue Market Share by Region (2021-2026)
Figure 57. APAC Drug Eluting Balloons (DEB) Sales Market Share by Type (2021-2026)
Figure 58. APAC Drug Eluting Balloons (DEB) Sales Market Share by Application (2021-2026)
Figure 59. China Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 63. India Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Drug Eluting Balloons (DEB) Sales Market Share by Country in 2026
Figure 67. Europe Drug Eluting Balloons (DEB) Revenue Market Share by Country (2021-2026)
Figure 68. Europe Drug Eluting Balloons (DEB) Sales Market Share by Type (2021-2026)
Figure 69. Europe Drug Eluting Balloons (DEB) Sales Market Share by Application (2021-2026)
Figure 70. Germany Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 71. France Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Drug Eluting Balloons (DEB) Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Drug Eluting Balloons (DEB) Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Drug Eluting Balloons (DEB) Sales Market Share by Application (2021-2026)
Figure 78. Egypt Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Drug Eluting Balloons (DEB) in 2026
Figure 84. Manufacturing Process Analysis of Drug Eluting Balloons (DEB)
Figure 85. Industry Chain Structure of Drug Eluting Balloons (DEB)
Figure 86. Channels of Distribution
Figure 87. Global Drug Eluting Balloons (DEB) Sales Market Forecast by Region (2027-2032)
Figure 88. Global Drug Eluting Balloons (DEB) Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Drug Eluting Balloons (DEB) Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Drug Eluting Balloons (DEB) Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Drug Eluting Balloons (DEB) Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Drug Eluting Balloons (DEB) Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Drug Eluting Balloons (DEB)
Figure 2. Drug Eluting Balloons (DEB) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug Eluting Balloons (DEB) Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Drug Eluting Balloons (DEB) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Drug Eluting Balloons (DEB) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Drug Eluting Balloons (DEB) Sales Market Share by Country/Region (2025)
Figure 10. Drug Eluting Balloons (DEB) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Peripheral DEBs
Figure 12. Product Picture of Coronary DEBs
Figure 13. Global Drug Eluting Balloons (DEB) Sales Market Share by Type in 2026
Figure 14. Global Drug Eluting Balloons (DEB) Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of In-Stent Restenosi
Figure 16. Product Picture of De Novo
Figure 17. Product Picture of Small Vessel
Figure 18. Global Drug Eluting Balloons (DEB) Sales Market Share by Use Scenario in 2026
Figure 19. Global Drug Eluting Balloons (DEB) Revenue Market Share by Use Scenario (2021-2026)
Figure 20. Product Picture of Semi-/Compliant
Figure 21. Product Picture of Non-compliant
Figure 22. Product Picture of Other
Figure 23. Global Drug Eluting Balloons (DEB) Sales Market Share by Balloon Platform Mechanics in 2026
Figure 24. Global Drug Eluting Balloons (DEB) Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Figure 25. Drug Eluting Balloons (DEB) Consumed in Catheterization Laboratory
Figure 26. Global Drug Eluting Balloons (DEB) Market: Catheterization Laboratory (2021-2026) & (K Units)
Figure 27. Drug Eluting Balloons (DEB) Consumed in Hospital
Figure 28. Global Drug Eluting Balloons (DEB) Market: Hospital (2021-2026) & (K Units)
Figure 29. Drug Eluting Balloons (DEB) Consumed in Others
Figure 30. Global Drug Eluting Balloons (DEB) Market: Others (2021-2026) & (K Units)
Figure 31. Global Drug Eluting Balloons (DEB) Sale Market Share by Application (2025)
Figure 32. Global Drug Eluting Balloons (DEB) Revenue Market Share by Application in 2026
Figure 33. Drug Eluting Balloons (DEB) Sales by Company in 2026 (K Units)
Figure 34. Global Drug Eluting Balloons (DEB) Sales Market Share by Company in 2026
Figure 35. Drug Eluting Balloons (DEB) Revenue by Company in 2026 ($ millions)
Figure 36. Global Drug Eluting Balloons (DEB) Revenue Market Share by Company in 2026
Figure 37. Global Drug Eluting Balloons (DEB) Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Drug Eluting Balloons (DEB) Revenue Market Share by Geographic Region in 2026
Figure 39. Americas Drug Eluting Balloons (DEB) Sales 2021-2026 (K Units)
Figure 40. Americas Drug Eluting Balloons (DEB) Revenue 2021-2026 ($ millions)
Figure 41. APAC Drug Eluting Balloons (DEB) Sales 2021-2026 (K Units)
Figure 42. APAC Drug Eluting Balloons (DEB) Revenue 2021-2026 ($ millions)
Figure 43. Europe Drug Eluting Balloons (DEB) Sales 2021-2026 (K Units)
Figure 44. Europe Drug Eluting Balloons (DEB) Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Drug Eluting Balloons (DEB) Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Drug Eluting Balloons (DEB) Revenue 2021-2026 ($ millions)
Figure 47. Americas Drug Eluting Balloons (DEB) Sales Market Share by Country in 2026
Figure 48. Americas Drug Eluting Balloons (DEB) Revenue Market Share by Country (2021-2026)
Figure 49. Americas Drug Eluting Balloons (DEB) Sales Market Share by Type (2021-2026)
Figure 50. Americas Drug Eluting Balloons (DEB) Sales Market Share by Application (2021-2026)
Figure 51. United States Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Drug Eluting Balloons (DEB) Sales Market Share by Region in 2026
Figure 56. APAC Drug Eluting Balloons (DEB) Revenue Market Share by Region (2021-2026)
Figure 57. APAC Drug Eluting Balloons (DEB) Sales Market Share by Type (2021-2026)
Figure 58. APAC Drug Eluting Balloons (DEB) Sales Market Share by Application (2021-2026)
Figure 59. China Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 63. India Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Drug Eluting Balloons (DEB) Sales Market Share by Country in 2026
Figure 67. Europe Drug Eluting Balloons (DEB) Revenue Market Share by Country (2021-2026)
Figure 68. Europe Drug Eluting Balloons (DEB) Sales Market Share by Type (2021-2026)
Figure 69. Europe Drug Eluting Balloons (DEB) Sales Market Share by Application (2021-2026)
Figure 70. Germany Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 71. France Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Drug Eluting Balloons (DEB) Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Drug Eluting Balloons (DEB) Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Drug Eluting Balloons (DEB) Sales Market Share by Application (2021-2026)
Figure 78. Egypt Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Drug Eluting Balloons (DEB) Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Drug Eluting Balloons (DEB) in 2026
Figure 84. Manufacturing Process Analysis of Drug Eluting Balloons (DEB)
Figure 85. Industry Chain Structure of Drug Eluting Balloons (DEB)
Figure 86. Channels of Distribution
Figure 87. Global Drug Eluting Balloons (DEB) Sales Market Forecast by Region (2027-2032)
Figure 88. Global Drug Eluting Balloons (DEB) Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Drug Eluting Balloons (DEB) Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Drug Eluting Balloons (DEB) Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Drug Eluting Balloons (DEB) Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Drug Eluting Balloons (DEB) Revenue Market Share Forecast by Application (2027-2032)
